Oncogene-dependent apoptosis in extracts from drug-resistant cells

Area of Science:

• Molecular Biology
• Cancer Research
• Virology

Background:

• Genotoxic chemotherapy agents induce apoptosis to kill tumor cells.
• Mutations suppressing apoptosis lead to chemoresistance.
• Selective activation of apoptotic pathways is needed to overcome resistance.

Purpose of the Study:

• To investigate mechanisms of chemoresistance and identify novel therapeutic targets.
• To determine if apoptosis can be selectively activated in drug-resistant cancer cells.
• To characterize a novel oncogene-derived activity that induces apoptosis.

Main Methods:

• Utilized drug-resistant 293 cell line and anticancer drug treatment.
• Performed cell-free assays using cell extracts to assess caspase activation.
• Compared extracts from cells with genetic differences, including adenovirus E1A expression.
• Partially purified oncogene generated activity (OGA) for further characterization.

Main Results:

• Drug-resistant cells failed to activate caspases (apoptosis machinery) upon drug treatment.
• Cell extracts from untreated cells spontaneously activated caspases and apoptosis.
• Adenovirus E1A oncogene was identified as the source of a caspase-activating factor, absent in normal cells.
• Partially purified OGA activated caspases in extracts from untransformed cells.

Conclusions:

• Drug-resistant cancer cells retain the apoptotic machinery and its activator.
• The adenovirus E1A oncogene produces an activity (OGA) that activates caspases.
• Targeting OGA or its downstream effects could provide selective therapy for chemoresistant tumors.